SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-17-003520
Filing Date
2017-04-12
Accepted
2017-04-12 16:34:14
Documents
5
Period of Report
2017-05-30
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1700099-def14a.htm DEF 14A 625698
2 GRAPHIC t1700099_pc1.jpg GRAPHIC 315824
3 GRAPHIC t1700099_pc2.jpg GRAPHIC 250598
4 GRAPHIC t1700099_pc3.jpg GRAPHIC 240881
5 GRAPHIC t1700099_pc4.jpg GRAPHIC 198966
  Complete submission text file 0001571049-17-003520.txt   1996620
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 17758312
SIC: 2834 Pharmaceutical Preparations